Fintel reports that on November 18, 2024, Stephens & Co. initiated coverage of Catalyst Pharmaceuticals (NasdaqCM:CPRX) with ...

While investors await the much-hyped 2026 debut of the R2, there's another big catalyst currently in danger for Rivian.

Seawater electrolysis has long been seen as a promising pathway for sustainable hydrogen production but has faced significant ...

U.S. venture capital giant General Catalyst has announced a fresh $8 billion in funds as it looks to ramp up its investments in multi-sector early-stage startups globally, with a specific focus on ...

Nobody would call General Catalyst a small fish. But there are a lot of new interesting details in recently released news, about how this VC firm is spending around $8 billion to pursue novel ...